Keros Therapeutics, Inc is a biopharmaceutical company based in Lexington, MA that is dedicated to developing innovative therapies for patients with disorders related to dysfunctional signaling of the transforming growth factor-beta (TGF-β) family of proteins. With a focus on hematological, pulmonary cardiovascular, and neuromuscular conditions, Keros leverages its deep expertise in TGF-β science to develop and commercialize novel therapeutics that have the potential to modulate TGF-β signaling and provide disease-modifying benefits for patients in need.
Driven by a passion for science and a commitment to their mission, Keros is at the forefront of cellular growth repair, aiming to shift the treatment paradigm for a wide range of patients. By harnessing the power of TGF-β biology, Keros is dedicated to advancing therapies that can unlock new possibilities for patients and improve their quality of life.
Generated from the website